Free tool
Stocks above their 200-day average
We cover 285 companies trading above their own 200-day average. The median market value in the group is $30.52M. Across the group, the median move over the past trading day is 0.00%. 100% of the 285 with a 200-day average trade above it. Price change over the past year runs from −36.4% to +132.2% across the middle 80 percent of the group, with a median of +10.8%.
Other lists in this group
Table
285 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LILY34.SA | Eli Lilly and Company | 211.20 BRL | +0.76% | +9.59% | +59.83% |
| LLY.DE | Eli Lilly and Company | 1,080.40 EUR | +0.43% | +19.60% | +73.55% |
| LLY | Eli Lilly and Company | $1,189.41 | −2.56% | +10.47% | +62.80% |
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% |
| JNJB34.SA | Johnson & Johnson | 92.80 BRL | +2.16% | +24.99% | +47.82% |
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% |
| 4AB.DE | AbbVie Inc. | 228.40 EUR | −2.56% | +19.14% | +32.34% |
| ABBV | AbbVie Inc. | $262.90 | −0.11% | +16.53% | +29.36% |
| ABBV34.SA | AbbVie Inc. | 84.88 BRL | −0.29% | +9.50% | +21.88% |
| MRCK34.SA | Merck & Co., Inc. | 101.37 BRL | +20.05% | +39.73% | +81.07% |
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% |
| RHO.DE | Roche Holding AG | 405.40 EUR | +2.01% | +14.00% | +41.42% |
| N1VS34.SA | Novartis AG | 81.76 BRL | +1.49% | +11.09% | +20.04% |
| NOT.DE | Novartis AG | 136.70 EUR | −1.56% | +19.69% | +28.89% |
| NVS | Novartis AG | $157.54 | −1.45% | +17.18% | +27.93% |
| AMGN34.SA | Amgen Inc. | 81.32 BRL | +13.94% | +69.69% | +47.79% |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% |
| TMOS34.SA | Thermo Fisher Scientific Inc. | 67.15 BRL | +9.49% | −0.22% | +22.22% |
| NVO.WA | Novo Nordisk A/S | 175.12 PLN | −10.34% | −1.45% | −9.22% |
| NOVO-B.CO | Novo Nordisk A/S | 307.80 DKK | −8.95% | −3.58% | −11.26% |
| NOV.DE | Novo Nordisk A/S | 41.42 EUR | −8.48% | +24.38% | +15.22% |
| N1VO34.SA | Novo Nordisk A/S | 30.41 BRL | −6.72% | −12.87% | −17.86% |
| NVO | Novo Nordisk A/S | $47.19 | −7.40% | −6.62% | −13.32% |
| ABL.DE | Abbott Laboratories | 98.74 EUR | +2.64% | −5.19% | −10.02% |
| NANOFH.HE | Nanoform Finland Oyj | 0.96 EUR | +9.34% | −18.64% | +15.66% |
| ILA.AX | Island Pharmaceuticals Limited | 0.45 AUD | +18.42% | +3.45% | +109.30% |
| 004080.KS | Shinhung Co., Ltd | 14,080.00 KRW | +0.28% | +0.57% | +2.54% |
| ATRA | Atara Biotherapeutics, Inc. | $9.38 | +20.10% | −47.21% | −24.05% |
| NANOFS.ST | Nanoform Finland Oyj | 10.94 SEK | +15.40% | −15.06% | +19.56% |
| ACRV | Acrivon Therapeutics, Inc. | $2.08 | +35.06% | −15.45% | +52.94% |
| BIOPOR.CO | BioPorto A/S | 1.24 DKK | +2.48% | +19.00% | −3.13% |
| ECOR | electroCore, Inc. | $10.35 | +69.95% | +127.47% | +86.49% |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | 68.60 SEK | +3.94% | +37.75% | +15.88% |
| ICCC | ImmuCell Corporation | $10.02 | −10.85% | +69.26% | +64.26% |
| 366A.T | WELLNESS COMMUNICATIONS CORPORA | 1,145.00 JPY | +12.48% | +7.77% | −23.84% |
| EAH.L | ECO Animal Health Group plc | 99.00 GBP | +1.54% | −6.60% | +34.69% |
| RLYB | Rallybio Corporation | $16.88 | +4.49% | +198.44% | +257.63% |
| 194A.T | WOLVES HAND CO LTD | 1,877.00 JPY | +48.73% | +8.18% | +102.92% |
| NANEXA.ST | Nanexa AB (publ) | 4.63 SEK | +14.46% | +15.03% | +100.43% |
| ATHE | Alterity Therapeutics Limited | $4.78 | +4.60% | +51.27% | −4.40% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | 6.40 SEK | +4.23% | +220.80% | +78.27% |
| BB1.AX | BLINKLAB FPO [BB1] | 0.80 AUD | +23.26% | −3.64% | +47.22% |
| CREO.L | Creo Medical Group PLC | 12.88 GBP | −5.50% | +26.85% | −1.90% |
| CING | Cingulate Inc. | $5.40 | +19.21% | +23.29% | +29.19% |
| 7792.T | Colan Totte.Co.,Ltd. | 1,484.00 JPY | +2.91% | +0.61% | +6.32% |
| ACET | Adicet Bio, Inc. | $8.95 | +9.15% | +1.47% | −26.01% |
| POLB.L | Poolbeg Pharma PLC | 8.60 GBP | +36.51% | +120.51% | +164.62% |
| HIGH.DE | Cantourage Group SE | 6.00 EUR | +5.63% | +80.72% | +51.90% |
| OBI.L | Ondine Biomedical Inc. | 11.75 GBP | −14.55% | +34.29% | −24.19% |
| INIFY.OL | INIFY Laboratories AB | 7.95 NOK | −3.05% | +65.63% | +44.55% |
| ATH.AX | Alterity Therapeutics Limited | 0.52 AUD | +0.98% | +14.44% | −14.17% |
| APLM | Apollomics, Inc. | $26.20 | +43.80% | +35.75% | +320.55% |
| OSTX | OS Therapies Incorporated | $1.65 | +10.00% | +23.13% | −34.00% |
| LONA | LeonaBio, Inc. | $7.81 | +12.05% | +12.21% | +95.25% |
| NRXS | NeurAxis, Inc. | $5.96 | −8.73% | +33.63% | +146.28% |
| MNOV | MediciNova, Inc. | $1.48 | +11.28% | +11.28% | +10.45% |
| KOO.L | Kooth plc | 146.00 GBP | −3.63% | +26.96% | −7.59% |
| FBIOP | Fortress Biotech, Inc. | $18.40 | −1.92% | +81.10% | +131.74% |
| ALTHX.PA | THX Pharma Société Anonyme | 4.18 EUR | +5.16% | +83.92% | +73.96% |
| 4875.T | MediciNova, Inc. | 229.00 JPY | +9.57% | +8.53% | +11.17% |
| 7702.T | JMS Co.,Ltd. | 459.00 JPY | +1.32% | +5.64% | +6.20% |
| ZLNA.OL | Zelluna ASA | 21.70 NOK | −2.25% | +55.00% | +56.57% |
| SAR.L | Sareum Holdings plc | 37.00 GBP | +76.19% | +117.65% | +76.19% |
| PMVP | PMV Pharmaceuticals, Inc. | $1.31 | +19.09% | +6.50% | −7.75% |
| INCR | InterCure Ltd. | $5.95 | +546.74% | +477.67% | +265.03% |
| 9341.T | GENOVA, Inc. | 634.00 JPY | −0.94% | +13.48% | +1.56% |
| INMB | INmune Bio Inc. | $2.45 | +42.98% | +58.77% | +19.56% |
| RNXT | RenovoRx, Inc. | $1.49 | +64.28% | +78.44% | +61.08% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | 311.00 JPY | +15.61% | +9.43% | +1.97% |
| SER | Serina Therapeutics, Inc. | $2.63 | +27.05% | +26.56% | −47.29% |
| AVE.AX | Avecho Biotechnology Limited | 0.02 AUD | +20.00% | +152.63% | +300.00% |
| BOLD | Boundless Bio, Inc. | $2.92 | +18.02% | +138.93% | +155.70% |
| 2934.T | J Frontier Co.,Ltd. | 1,944.00 JPY | +7.11% | +47.61% | −2.11% |
| TLPH | Talphera, Inc. | $1.26 | −3.08% | +8.62% | +133.33% |
| R0L.F | J Frontier Co.,Ltd. | 10.30 EUR | +10.75% | −44.02% | −44.02% |
| MYO | Myomo, Inc. | $1.53 | +60.21% | +54.55% | +36.61% |
| INKT | MiNK Therapeutics, Inc. | $11.79 | +11.86% | +6.03% | −26.22% |
| 9265.T | Yamashita Health Care Holdings,Inc. | 3,745.00 JPY | +7.61% | +16.27% | +24.40% |
| XLO | Xilio Therapeutics, Inc. | $9.05 | −1.09% | −3.81% | −5.63% |
| 7133.T | HYUGA PRIMARY CARE Co.,Ltd. | 1,300.00 JPY | +5.95% | +15.08% | −0.72% |
| 4524.T | Morishita Jintan Co., Ltd. | 2,241.00 JPY | +0.86% | +4.83% | +4.22% |
| COCH | Envoy Medical, Inc. | $0.74 | +8.39% | +5.75% | −37.09% |
| 4896.T | K Pharma,Inc. | 763.00 JPY | +6.71% | +13.88% | +14.56% |
| SCYX | SCYNEXIS, Inc. | $5.67 | +56.20% | +787.32% | +579.04% |
| ALTHE.PA | Theraclion SA | 0.63 EUR | +6.55% | +3.93% | −22.30% |
| ALSMA.PA | S.M.A.I.O S.A. | 7.60 EUR | −2.56% | +23.58% | +14.29% |
| NTRB | Nutriband Inc. | $4.50 | +52.28% | +1.58% | −29.80% |
| PRPO | Precipio, Inc. | $30.41 | +34.12% | +27.64% | +99.25% |
| ATX.AX | Amplia Therapeutics Limited | 0.15 AUD | +11.54% | −14.71% | −14.71% |
| EPIS-B.ST | Episurf Medical AB (publ) | 0.08 SEK | +37.70% | +90.12% | +71.52% |
| OHGR.L | One Health Group Plc | 292.50 GBP | +10.38% | +16.53% | +17.03% |
| 4572.T | Carna Biosciences, Inc. | 402.00 JPY | +37.67% | 0.00% | +81.90% |
| MOB.ST | Moberg Pharma AB (publ) | 10.70 SEK | +9.52% | +4.49% | +32.92% |
| 9218.T | Mental Health Technologies Co.,Ltd. | 778.00 JPY | +5.14% | −4.31% | −7.41% |
| 4597.T | Solasia Pharma K.K. | 30.00 JPY | +3.45% | +7.14% | −18.92% |
| ENP.AX | Entropy Neurodynamics Limited | 0.04 AUD | +17.14% | +28.12% | +10.81% |
| HOWL | Werewolf Therapeutics, Inc. | $0.99 | +120.22% | +53.30% | −25.65% |
| MLSS | Milestone Scientific Inc. | $0.54 | +25.44% | +86.00% | −10.10% |
| 3628.T | Data Horizon Co.,Ltd. | 592.00 JPY | −0.84% | +19.60% | +7.64% |
| ALGS | Aligos Therapeutics, Inc. | $7.51 | +76.71% | −17.74% | −33.72% |
| IMMU.ST | Mendus AB (publ) | 7.10 SEK | +2.60% | +23.05% | −4.57% |
| CLBIO.ST | Corline Biomedical AB | 18.85 SEK | +6.80% | +8.96% | +45.56% |
| ELUT | Elutia Inc. | $1.00 | +9.29% | +55.52% | −54.75% |
| 9340.T | ASO International, Inc. | 714.00 JPY | +0.28% | −1.79% | +0.18% |
| NEPH | Nephros, Inc. | $4.05 | +15.71% | −14.74% | 0.00% |
| CTE.AX | Cryosite Limited | 1.25 AUD | +4.17% | +25.00% | +56.25% |
| ONCIN.OL | Oncoinvent ASA | 85.00 NOK | −2.07% | +80.85% | +10.90% |
| ALCOX.PA | Nicox S.A. | 0.38 EUR | +0.79% | +21.76% | +2.70% |
| ALNOV.PA | Novacyt S.A. | 0.51 EUR | +16.21% | +21.19% | +7.38% |
| NCYT.L | Novacyt S.A. | 43.50 GBP | +17.73% | +21.00% | +7.81% |
| 4893.T | Noile-Immune Biotech Inc. | 148.00 JPY | +11.28% | +10.45% | −16.38% |
| 206A.T | PRISM BioLab Co.,LTD | 170.00 JPY | +18.06% | +5.59% | −5.56% |
| 002630.KS | ORIENT BIO Inc. | 919.00 KRW | +4.31% | +49.19% | +49.67% |
| PKY.AX | Pathkey.AI Ltd | 0.04 AUD | +44.44% | +143.75% | +77.27% |
| IVACC.ST | Intervacc AB (publ) | 1.10 SEK | −14.11% | +17.98% | +4.78% |
| 7980.T | Shigematsu Works Co., Ltd. | 855.00 JPY | +3.51% | +10.49% | +6.69% |
| MVP.AX | Medical Developments International Limited | 0.47 AUD | +2.20% | −15.45% | −19.83% |
| 7707.T | Precision System Science Co., Ltd. | 218.00 JPY | +10.10% | +14.74% | +6.34% |
| 7681.T | LEOCLAN Co.,Ltd. | 999.00 JPY | +4.61% | −2.15% | −10.99% |
| ALMKT.PA | Mauna Kea Technologies SA | 0.15 EUR | −0.39% | +95.44% | +47.33% |
| ABDX.L | Abingdon Health Plc | 10.75 GBP | +4.88% | +67.97% | +104.76% |
| 7091.T | Living Platform,Ltd. | 1,285.00 JPY | +7.98% | +22.20% | +34.42% |
| SPRINT.ST | Sprint Bioscience AB (publ) | 3.15 SEK | −15.32% | +111.41% | +458.51% |
| ALGEN.PA | genOway Société anonyme | 2.46 EUR | −0.81% | −8.89% | −18.00% |
| BIOWKS.ST | Bio-Works Technologies AB (publ) | 3.31 SEK | −10.78% | +14.53% | +4.75% |
| HBIO | Harvard Bioscience, Inc. | $7.65 | +29.22% | +17.69% | +44.34% |
| PTG.WA | Poltreg S.A. | 25.00 PLN | +9.17% | −1.96% | −14.68% |
| CCEL | Cryo-Cell International, Inc. | $4.25 | +25.74% | +23.91% | −3.19% |
| NSYS | Nortech Systems Incorporated | $11.78 | −18.53% | +58.55% | +30.74% |
| KYNB | Kyntra Bio, Inc. | $8.11 | +16.20% | −11.52% | −22.66% |
| PXS.L | Provexis plc | 1.09 GBP | −7.63% | +23.16% | +51.39% |
| 4172.T | Hi-CRATES CO.,LTD. | 2,317.00 JPY | +3.25% | −0.22% | +3.74% |
| BRAIN.ST | BrainCool AB (publ) | 0.73 SEK | −1.22% | +21.87% | −21.51% |
| SIGHT.PA | GenSight Biologics S.A. | 0.12 EUR | +46.83% | +5.61% | −25.31% |
| RMTI | Rockwell Medical, Inc. | $7.92 | +13.23% | +820.35% | +438.44% |
| QNCX | Quince Therapeutics, Inc. | $31.31 | +61.64% | +4.37% | +100.71% |
| IGC | IGC Pharma, Inc. | $0.31 | +18.35% | +6.10% | −31.62% |
| ALDVI.PA | Advicenne S.A. | 1.75 EUR | +4.79% | −6.02% | +39.11% |
| 4591.T | Ribomic Inc. | 86.00 JPY | +21.13% | +10.26% | −17.31% |
| NXN.AX | Nexsen Ltd | 0.21 AUD | −12.50% | +40.00% | −25.00% |
| MBX.TO | Microbix Biosystems Inc. | 0.31 CAD | −1.61% | +27.08% | +27.08% |
| EYE.AX | Nova Eye Medical Limited | 0.15 AUD | +15.38% | +7.14% | +3.45% |
| GDR.L | genedrive plc | 1.30 GBP | +33.33% | +48.57% | +67.74% |
| BRNS | Barinthus Biotherapeutics plc | $0.71 | +23.93% | −3.89% | −38.04% |
| GRDX | GridAI Technologies Corp. | $4.04 | +35.12% | −21.40% | +111.52% |
| NN6.DE | NanoRepro AG | 1.85 EUR | −5.38% | +19.81% | −4.90% |
| 6545.T | internet infinity Inc. | 823.00 JPY | +0.24% | +24.33% | +34.23% |
| IRLAB-A.ST | IRLAB Therapeutics AB (publ) | 1.75 SEK | +32.27% | −13.13% | −44.31% |
| SOFTX.OL | SoftOx Solutions AS | 0.10 NOK | +16.03% | +13.60% | −15.04% |
| ISOFOL.ST | Isofol Medical AB (publ) | 0.84 SEK | +5.79% | +12.60% | −1.87% |
| KLAR.ST | Klaria Pharma Holding AB (publ.) | 1.05 SEK | +32.58% | +50.57% | +97.38% |
| TXMD | TherapeuticsMD, Inc. | $2.28 | +10.68% | +38.18% | +103.57% |
| OSL.AX | OncoSil Medical Limited | 1.16 AUD | +4.50% | +19.59% | +0.87% |
| RENX.L | Renalytix Plc | 4.30 GBP | +62.26% | −27.12% | −26.50% |
| INTEG-B.ST | Integrum AB (publ) | 8.66 SEK | −0.92% | −16.73% | −79.55% |
| MRKR | Marker Therapeutics, Inc. | $1.45 | +22.88% | −5.84% | +54.26% |
| RUA.L | RUA Life Sciences plc | 28.00 GBP | +9.80% | +103.64% | +130.93% |
| FEMY | Femasys Inc. | $2.92 | 0.00% | +358.40% | +711.11% |
| LABS.TO | MediPharm Labs Corp. | 0.08 CAD | +6.67% | +14.29% | +6.67% |
| ALTAO.PA | Aton | 0.02 EUR | +94.12% | +182.86% | +153.85% |
| BFRI | Biofrontera Inc. | $1.53 | +37.84% | +111.03% | +77.91% |
| 4884.T | Kringle Pharma, Inc. | 440.00 JPY | +42.86% | +12.24% | −11.29% |
| RVP | Retractable Technologies, Inc. | $0.73 | +8.96% | −3.95% | −12.05% |
| COCP | Cocrystal Pharma, Inc. | $1.12 | +20.43% | +13.13% | −27.74% |
| CCM | Concord Medical Services Holdings Limited | $4.96 | +7.83% | +16.16% | −10.47% |
| ALLR | Allarity Therapeutics, Inc. | $1.34 | +13.56% | +17.54% | −15.72% |
| LFWD | Lifeward Ltd. | $7.49 | +7.74% | +0.03% | +0.03% |
| 7129.T | Miahelsa Holdings Corporation | 1,155.00 JPY | +0.09% | +2.17% | +4.87% |
| RHT.AX | Resonance Health Limited | 0.06 AUD | −1.67% | +25.53% | +43.90% |
| PMI | Picard Medical, Inc. | $9.80 | +122.73% | +438.46% | +113.51% |
| DEX.ST | Dextech Medical AB | 10.30 SEK | −0.96% | +11.35% | +26.38% |
| NOX.AX | Noxopharm Limited | 0.09 AUD | −2.17% | −4.26% | −10.00% |
| NCEL | NewcelX Ltd. | $3.38 | −2.87% | +61.72% | −84.77% |
| 9220.T | FB Care Service Co.,Ltd. | 1,287.00 JPY | +3.96% | +12.06% | +11.55% |
| CLBX.L | CelLBxHealth plc | 1.25 GBP | −1.96% | +13.64% | −79.17% |
| ALBIO.PA | Biosynex SA | 0.90 EUR | −0.88% | +56.06% | −23.23% |
| VYNE | VYNE Therapeutics Inc | $28.56 | +3080.40% | +4824.14% | +8660.74% |
| 5619.T | MRSO INC | 900.00 JPY | +1.35% | +1.69% | −16.43% |
| LEXX | Lexaria Bioscience Corp. | $11.04 | +36.30% | +1588.07% | +1146.05% |
| ALINS.PA | Intrasense S.A. | 0.30 EUR | +34.55% | +29.26% | −0.34% |
| BCDA | BioCardia, Inc. | $1.19 | +52.56% | −6.30% | −38.66% |
| CYCN | Cyclerion Therapeutics, Inc. | $4.15 | +18.57% | +209.70% | +61.48% |
| ALTME.PA | TME Pharma N.V. | 0.13 EUR | +113.11% | +88.41% | +25.97% |
| BIVI | BioVie Inc. | $2.11 | +58.65% | +58.65% | +30.25% |
| ALZ.ST | Alzinova AB (publ) | 0.84 SEK | −13.70% | +0.48% | −39.02% |
| 7813.T | Platz Co., Ltd. | 877.00 JPY | +10.04% | +9.76% | +18.51% |
| ABERA.ST | Abera Bioscience AB | 8.18 SEK | −2.62% | +13.61% | +1.61% |
| ADIL | Adial Pharmaceuticals, Inc. | $5.94 | +101.36% | −1.00% | −37.47% |
| HEART.ST | Scandinavian Real Heart AB (Publ) | 18.70 SEK | −3.86% | +34.05% | +3.31% |
| CMMB | Chemomab Therapeutics Ltd. | $2.59 | +81.12% | +44.69% | −25.57% |
| ALEMG.PA | Laboratoires Euromedis Société anonyme | 4.96 EUR | −3.69% | +26.53% | +18.10% |
| 6063.T | Emergency Assistance Japan Co., Ltd. | 999.00 JPY | −0.79% | +11.50% | +0.89% |
| THAT.L | Thalia Therapeutics Plc | 0.65 GBP | −3.70% | +23.81% | +52.94% |
| BTC.AX | BTC Health Limited | 0.06 AUD | +15.09% | −1.61% | −1.61% |
| ADVB | Advanced Biomed Inc. | $9.24 | −15.07% | +52.98% | +13.24% |
| ORTI-B.ST | Ortivus AB (publ) | 1.62 SEK | −13.83% | +32.79% | +42.11% |
| ICR.AX | Intelicare Holdings Limited | 0.03 AUD | +26.09% | +20.83% | +75.76% |
| ACTI.ST | Active Biotech AB (publ) | 5.50 SEK | +6.38% | +19.57% | −62.00% |
| OBSRV.OL | Observe Medical ASA | 1.00 NOK | −5.85% | +42.57% | +5.05% |
| NTI.AX | Neurotech International Limited | 0.02 AUD | −6.25% | +3.45% | +15.38% |
| 189A.T | D&M COMPANY CO LTD | 983.00 JPY | −1.70% | +7.28% | +9.26% |
| 7083.T | AHC Group Inc. | 1,084.00 JPY | +3.34% | +23.18% | +16.95% |
| PHIO | Phio Pharmaceuticals Corp. | $1.20 | +18.81% | +10.09% | −40.89% |
| IDT.AX | IDT Australia Limited | 0.05 AUD | +28.57% | −16.67% | −30.77% |
| BIOVIC-B.ST | Biovica International AB (publ) | 0.45 SEK | −9.46% | +4.41% | −30.12% |
| SIMRIS-B.ST | Simris Group AB (PUBL) | 0.10 SEK | −23.09% | +125.34% | −28.35% |
| HSCS | HeartSciences Inc. | $2.99 | +32.30% | −4.78% | −11.54% |
| ICO.ST | Iconovo AB (publ) | 1.26 SEK | +26.00% | +12.50% | −52.09% |
| NXTCL.ST | NextCell Pharma AB | 1.12 SEK | +4.69% | +58.97% | −5.10% |
| 6029.T | Artra Group Corporation | 189.00 JPY | −4.06% | +8.00% | −19.57% |
| CRTX.L | CRISM Therapeutics Corporation | 11.50 GBP | +21.05% | +15.00% | +9.52% |
| APRE | Aprea Therapeutics, Inc. | $0.98 | +59.61% | +14.89% | −38.75% |
| ARCOMA.ST | Arcoma AB | 8.26 SEK | +2.74% | +14.72% | −2.13% |
| ALBPS.PA | Biophytis S.A. | 0.08 EUR | +422.88% | +28.41% | −50.31% |
| ASBP | Aspire Biopharma Holdings, Inc. | $8.33 | +14.98% | +52.01% | −60.93% |
| KPRX | Kiora Pharmaceuticals, Inc. | $2.59 | +0.78% | +28.22% | −9.44% |
| TOVX | Theriva Biologics, Inc. | $0.24 | +15.81% | −6.46% | −42.10% |
| ALAMA.PA | AMA Corporation Plc | 0.17 EUR | +21.07% | −0.59% | −34.56% |
| LUCY | Lucyd, Inc | $1.13 | +52.50% | −0.88% | −42.05% |
| IDLDX.ST | IDL Diagnostics AB (publ) | 0.41 SEK | −3.28% | +19.36% | −2.36% |
| MBAI | Check-Cap Ltd. | $6.78 | +545.71% | +295.34% | +943.08% |
| BMGL | Basel Medical Group Ltd | $5.94 | −6.83% | +939.40% | +202.81% |
| IMRN | Immuron Limited | $1.14 | +4.11% | +43.40% | −35.77% |
| XBIO | Xenetic Biosciences, Inc. | $3.86 | +54.40% | +79.53% | +35.92% |
| SKYE | Skye Bioscience, Inc. | $2.02 | +228.46% | +130.07% | −41.62% |
| XWEL | XWELL, Inc. | $1.00 | −5.16% | +121.29% | −6.93% |
| CNSP | CNS Pharmaceuticals, Inc. | $5.44 | +7.30% | +2.64% | −13.51% |
| 7362.T | Terminalcare Support Institute Inc. | 879.00 JPY | +2.45% | +11.41% | +3.53% |
| NEWBRY.ST | Newbury Pharmaceuticals AB (publ) | 2.57 SEK | −6.55% | +110.66% | −0.39% |
| PRE.MI | Predict S.p.A. | 0.93 EUR | +3.33% | +19.23% | +7.51% |
| NDRA | ENDRA Life Sciences Inc. | $5.44 | +21.97% | +26.81% | +32.36% |
| ALZN | Alzamend Neuro, Inc. | $1.67 | +27.48% | −12.11% | −32.11% |
| NVNO | enVVeno Medical Corporation | $11.47 | +10.27% | −6.39% | −63.76% |
| ICCM | IceCure Medical Ltd | $2.29 | −17.92% | +263.49% | +132.49% |
| TRIB | Trinity Biotech plc | $9.59 | −22.97% | +1178.67% | +547.97% |
| PILA.ST | Pila Pharma AB (publ) | 1.68 SEK | +45.45% | −17.24% | −15.41% |
| INM | InMed Pharmaceuticals Inc. | $1.43 | −14.37% | +27.68% | −36.44% |
| CODE.OL | CodeLab Capital AS | 3.40 NOK | +5.59% | +41.67% | +22.74% |
| CURX | Curanex Pharmaceuticals Inc | $4.60 | +2223.23% | +1150.00% | −1.29% |
| 011000.KS | GeneOne Life Science, Inc. | 2,670.00 KRW | 0.00% | +35.33% | +18.40% |
| IXC.AX | Invex Therapeutics Ltd | 0.13 AUD | +18.18% | +4.00% | +30.00% |
| JUNS | Jupiter Neurosciences, Inc. | $5.01 | +4454.55% | +396.04% | +236.24% |
| VBS.AX | Vectus Biosystems Limited | 0.17 AUD | +30.77% | +3.03% | +104.82% |
| MODTX.ST | Modus Therapeutics Holding AB (publ) | 0.37 SEK | +0.54% | +19.35% | −85.49% |
| CTQ.AX | Careteq Limited | 0.01 AUD | 0.00% | +9.09% | +20.00% |
| AMIX | Autonomix Medical, Inc. | $6.38 | +132.00% | +1088.08% | +440.68% |
| LIMN | Liminatus Pharma, Inc. | $4.41 | +4140.38% | +587.99% | +46.03% |
| PEXA-B.ST | PExA AB (publ) | 0.34 SEK | −31.80% | +48.26% | +79.47% |
| STRAP.CO | Strategic Partners A/S | 740.00 DKK | +2.07% | +0.27% | −28.50% |
| CSCI.TO | COSCIENS Biopharma Inc. | 7.30 CAD | −7.59% | +151.72% | +60.79% |
| SERV.ST | Servana AB | 0.01 SEK | −16.22% | +210.00% | +106.67% |
| FLUI.ST | Fluicell AB (publ) | 34.60 SEK | +14.57% | +246.00% | +247.74% |
| HCWB | HCW Biologics Inc. | $2.70 | +4.45% | +141.07% | −55.15% |
| XAIR | Beyond Air, Inc. | $4.97 | −8.97% | +529.91% | +117.98% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.33 | +710.86% | +426.12% | +211.51% |
| APS.TO | Aptose Biosciences Inc | 2.40 CAD | 0.00% | +18.81% | +50.00% |
| SILO | Silo Pharma, Inc. | $2.50 | −43.95% | +644.05% | +290.62% |
| AINO.ST | Aino Health AB (publ) | 0.20 SEK | +2.06% | +3.66% | −10.81% |
| ADR.AX | Adherium Limited | 0.10 AUD | −4.76% | +1900.00% | +1900.00% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | 0.16 SEK | +30.42% | +16.79% | +11.79% |
| UPC | Universe Pharmaceuticals INC | $5.32 | +66.77% | +27.88% | +44.57% |
| CLDI | Calidi Biotherapeutics, Inc. | $1.35 | −21.14% | +14.41% | −19.16% |
| TNON | Tenon Medical, Inc. | $5.21 | +2642.11% | +434.91% | +297.71% |
| GNPX | Genprex, Inc. | $3.97 | −50.56% | +121.79% | −54.10% |
| PYC.L | Physiomics Plc | 0.52 GBP | +7.29% | +80.70% | +21.18% |
| MONSO.CO | Monsenso A/S | 0.26 DKK | −19.25% | +73.33% | +23.81% |
| SPERM.ST | Spermosens AB (publ) | 0.01 SEK | −10.20% | +57.14% | +15.79% |
| TD1.AX | TALi Digital Limited | 0.09 AUD | +11.11% | +73.08% | −10.00% |
| BIAF | bioAffinity Technologies, Inc. | $5.09 | +710.51% | +317.21% | −31.59% |
| PFSA | Profusa, Inc. | $4.26 | +309.13% | −43.27% | −86.13% |
| VRAX | Virax Biolabs Group Limited | $2.77 | −4.15% | +621.35% | +365.55% |
| PHAL.ST | PharmaLundensis AB | 0.32 SEK | 0.00% | +8.19% | +37.83% |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | $3.59 | +28.67% | +98.34% | +7.65% |
| MNDR | Mobile-health Network Solutions | $1.64 | −1.80% | +72.63% | −69.91% |
| RESP.ST | Respiratorius AB (publ) | 2.28 SEK | +3.17% | +31.03% | −39.20% |
| 27N0.DE | Cannovum Cannabis AG | 0.56 EUR | +10.76% | +24.94% | +22.47% |
| BIG1.DE | Bio-Gate AG | 2.83 EUR | −14.39% | +262.18% | +200.53% |
| SCNI | Scinai Immunotherapeutics Ltd. | $2.87 | +987.12% | +293.15% | +93.92% |
| ALINT.PA | IntegraGen SA | 0.18 EUR | −18.86% | +32.22% | −36.25% |
| APM | Aptorum Group Ltd | $8.41 | −6.45% | +685.98% | +273.78% |
| ALNEV.PA | Neovacs S.A. | 0.55 EUR | −31.22% | +6150.00% | −11.29% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.